miRNAs and Melanoma: How Are They Connected? by Adriana Taveira da Cruz, Miriam Galvonas Jasiulionis

“…Therefore, this review aims to discuss new findings about miRNAs in melanoma fields, underlying epigenetic processes, and also to argue possibilities of using miRNAs in melanoma diagnosis and therapy.…”
Get full text

Role of the androgen receptor in melanoma aggressiveness by Marzia Di Donato, Costanza Maria Cristiani, Mariaelena Capone, Cinzia Garofalo, Gabriele Madonna, Lucia Carmela Passacatini, Margaret Ottaviano, Paolo Antonio Ascierto, Ferdinando Auricchio, Ennio Carbone, Antimo Migliaccio, Gabriella Castoria

“…Abstract Malignant melanoma represents the fifth most common cancer in the world and its incidence is rising. …”
Get full text

Outcomes of Treatment for Melanoma Brain Metastases by Mantas Janavicius, Nadezda Lachej, Giedre Anglickiene, Ieva Vincerzevskiene, Birute Brasiuniene

“…Background. Historically, melanoma with brain metastases has a poor prognosis. …”
Get full text

Inhibition of programmed cell death by melanoma cell subpopulations reveals mechanisms of melanoma metastasis and potential therapeutic targets by Yuepeng An, Fu Zhao, Hongling Jia, Siyu Meng, Ziwei Zhang, Shuxiao Li, Jiusi Zhao

Subjects: “…Melanoma…”
Get full text

Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea by Joon Min Jung, Do Hyung Kim, Ye-Jee Kim, Ik Jun Moon, Woo Jin Lee, Sung Eun Chang, Mi Woo Lee, Chong Hyun Won

Subjects: “…Melanoma…”
Get full text

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients by Haike M. J. van der Velden, Michelle M. van Rossum, Willeke A. M. Blokx, Jan B. M. Boezeman, Marie-Jeanne P. Gerritsen

“…The increasing number of living cutaneous melanoma patients and the increased risk of developing a second primary tumour incited us to analyse the clinical characteristics of cutaneous melanoma and define the frequency, site, and type of second primary cancers in cutaneous melanoma patients. …”
Get full text

Advances in Immunotherapy for Melanoma: A Comprehensive Review by Carmen Rodríguez-Cerdeira, Miguel Carnero Gregorio, Adriana López-Barcenas, Elena Sánchez-Blanco, Beatriz Sánchez-Blanco, Gabriella Fabbrocini, Brunilda Bardhi, Ardiana Sinani, Roberto Arenas Guzman

“…Melanomas are tumors originating from melanocytes and tend to show early metastasis secondary to the loss of cellular adhesion in the primary tumor, resulting in high mortality rates. …”
Get full text

Acral Lentiginous Melanoma Presenting with Amelanotic Metastasis by Alaka J Mohan, AjithkumarKidanga zhiyathmana, Neelakandhan Asokan

Subjects: “…acral melanoma…”
Get full text

Immune Checkpoint Blockade in Melanoma – Earlier is Better? by Vincas Urbonas, Audrius Dulskas, Edita Baltruškevičienė, Daiva Dabkevičienė

Subjects: “…Melanoma…”
Get full text

Worldwide Increasing Incidences of Cutaneous Malignant Melanoma by Dianne E. Godar

“…The incidence of cutaneous malignant melanoma (CMM) has been increasing at a steady rate in fair-skinned populations around the world for decades. …”
Get full text

Marital Status and Survival in Patients Diagnosed with Melanoma by J. A. Maas, A. J. Monreal, E. L. Diaz, G. Castro, P. Rodriguez de la Vega, M. Varella

“…Yet, the role of marital status on melanoma survival is currently unknown. The aim of this study is to assess whether marital status is associated with survival following melanoma diagnosis. …”
Get full text

Endoscopic Detection of Gastric Metastases in Skin Melanoma by M. Yu. Kabanov, K. V. Sementsov, D. B. Degterev, M. Ya. Belikova, D. K. Savchenkov, T. E. Koshelev, A. K. Stechishina

“…A clinical description of disseminated skin melanoma with endoscopic observation of its pathognomonic pigmented metastases into the stomach.Key points. …”
Get full text

Melanoma of the Right Foot Simulating Kaposi’s Disease by K. A. Kouassi, K. Kassi, K. Kouamé, M. A. Oussou, I. Kouassi, I. P. Gbery, E. J. Ecra, A. Sangare, C. Ahogo, M. Kaloga, P. Yoboue, J. M. Kanga

“…Melanoma is a malignant tumor rarely being described in sub-Saharan Africa. …”
Get full text

Application of adoptive cell therapy in malignant melanoma by Qianrong Hu, Jiangying Xuan, Lu Wang, Kangjie Shen, Zixu Gao, Yuhong Zhou, Chuanyuan Wei, Jianying Gu

Subjects: Get full text

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma by Fabio Morandi, Francesco Frassoni, Mirco Ponzoni, Chiara Brignole

“…Neuroblastoma (NB) and malignant melanoma (MM), tumors of pediatric age and adulthood, respectively, share a common origin, both of them deriving from the neural crest cells. …”
Get full text

Radiotherapy for Melanoma: More than DNA Damage by Susanne J. Rogers, Emsad Puric, Brigitte Eberle, Niloy R. Datta, Stephan B. Bodis

“…Despite its reputation as a radioresistant tumour, there is evidence to support a role for radiotherapy in patients with melanoma and we summarise current clinical practice. …”
Get full text

Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma by Xue Wang, Shanshan Ma, Shuting Zhu, Liucun Zhu, Wenna Guo

Subjects: “…malignant melanoma…”
Get full text

Sonography of the Primary Cutaneous Melanoma: A Review by Ximena Wortsman

“…The diagnosis and management of primary cutaneous melanoma have traditionally relied on clinical and histological characteristics. …”
Get full text

Focus on Adoptive T Cell Transfer Trials in Melanoma by Liat Hershkovitz, Jacob Schachter, Avraham J. Treves, Michal J. Besser

“…Adoptive Cell Transfer (ACT) of Tumor-Infiltrating Lymphocytes (TIL) in combination with lymphodepletion has proven to be an effective treatment for metastatic melanoma patients, with an objective response rate in 50%–70% of the patients. …”
Get full text

Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma by Corina Daniela Ene, Mircea Tampa, Ilinca Nicolae, Cristina Iulia Mitran, Madalina Irina Mitran, Clara Matei, Ana Caruntu, Constantin Caruntu, Simona Roxana Georgescu

“…We performed an observational study that included 380 subjects subdivided into three groups: patients with metastatic melanoma (170 cases), patients with primary melanoma (160 cases), and healthy subjects (50 subjects). …”
Get full text